Subtypes of Hypertension 2 to 7 Years After First Pregnancy
- 9 June 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8)
Abstract
BACKGROUND: Isolated diastolic hypertension can precede combined systolic-diastolic hypertension, suggesting isolated diastolic hypertension may be a risk factor for adverse cardiovascular outcomes. Little is known about the prevalence of hypertensive subtypes (isolated diastolic, isolated systolic, or combined systolic-diastolic hypertension) in the years after first pregnancy, and whether these differ after hypertensive disorder of pregnancy. METHODS: This is a secondary analysis (conducted 2023–2024) of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study. Nulliparas were enrolled at 8 US clinical sites from 2010 to 2013; participants who completed the Heart Health Study visit 2 to 7 years after pregnancy were eligible. Blood pressures were elevated at the visit if systolic was ≥130 mm Hg and diastolic ≥80 mm Hg. Multinomial logistic regression relative risk models were adjusted for age, body mass index, race, and time from pregnancy to visit. RESULTS: Four thousand three hundred two participants were included. Mean age at Heart Health Study visit was 30.7 years (SD, 5.6 years); 812 (19%) had elevated blood pressure. Isolated diastolic hypertension was most prevalent (n=627; 15%). Compared with normotensive pregnancy, hypertensive disorders of pregnancy were associated with combined systolic-diastolic (adjusted risk ratio, 3.09 [95% CI, 2.21–4.31]) and isolated diastolic hypertension (adjusted risk ratio, 1.65 [95% CI, 1.36–2.00]). CONCLUSIONS: Isolated diastolic hypertension is the most prevalent hypertensive subtype after first pregnancy. Women with hypertensive disorders of pregnancy had increased risk of combined systolic-diastolic and isolated diastolic hypertension. Given the high prevalence of isolated diastolic hypertension found in this cohort, postpartum women represent a subgroup with opportunity for cardiovascular risk reduction. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02231398.Keywords
This publication has 53 references indexed in Scilit:
- Sex Differences in the Prevalence, Outcomes and Management of HypertensionCurrent Hypertension Reports, 2022
- Sex Differences in Blood Pressure Trajectories Over the Life CourseJAMA Cardiology, 2020
- Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular OutcomesJAMA, 2020
- Comparison of US Birth Weight References and the International Fetal and Newborn Growth Consortium for the 21st Century StandardJAMA Pediatrics, 2015
- A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b)American Journal of Obstetrics and Gynecology, 2015
- Cardiovascular Risks Associated With Diastolic Blood Pressure and Isolated Diastolic HypertensionCurrent Hypertension Reports, 2014
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010JAMA, 2012
- Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analysesAmerican Heart Journal, 2008
- Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressureStatistics in Medicine, 2005
- A united states national reference for fetal growthObstetrics & Gynecology, 1996